TG Biotech is a pioneering biotech venture that made history in 2004 by discovering the world’s first obesity gene and, in 2007, developing Actiponin®, a groundbreaking obesity treatment ingredient derived from natural sources.
Our expertise led us to supply the No.1-selling health supplements on Amazon and iHerb in 2024.
As a result of our cutting-edge research, we proudly launched Actifit, our first proprietary brand, revolutionizing the functional health supplement market.

Our leadership team includes distinguished experts from institutions such as:
• National Institutes of Health (NIH), USA
• KAIST (Ph.D. in Science)
• Kyungpook National University (Ph.D. in Genetic Engineering)
• Osaka Medical College (Ph.D.)
Additionally, our advisory panel comprises specialists from:
• Harvard Medical School (Ph.D.)
• Johns Hopkins University (Ph.D.)
• KAIST Department of Life Sciences (Professor)
• Seoul National University College of Pharmacy (Ph.D.)
• Kyoto University, Japan (Ph.D.)